Business Wire

LivaNova’s Perceval Sutureless Aortic Heart Valve Receives National Reimbursement in Japan to Treat Patients with Aortic Valve Disease

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that Japan’s Ministry of Health, Labour and Welfare granted national reimbursement for ...
Business Wire

LivaNova Announces Enrollment for PERFECT Perceval Valve Clinical Trial in China

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, has announced the first patient enrollment in the Perceval ® Valve ...
Nasdaq

LivaNova Announces Commercial Launch of Perceval Plus Aortic Heart Valve in Europe

The next-generation sutureless surgical technology is based on a clinically proven platform and designed for valve durability Perceval Plus is the next generation of Perceval, which is a trusted ...
TCTMD

LivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients

LONDON, LivaNova, PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, announced the presentation of data from multiple studies demonstrating ...
Finanznachrichten

LivaNova's Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-on Payment from the Center for Medicare and Medicaid Services

LivaNova PLC (NASDAQ:LIVN) ("LivaNova" or the "Company"), a market-leading medical technology company, today announced its Perceval sutureless aortic heart valve received approval from the Centers for ...
Nasdaq

New Data on LivaNova Perceval Sutureless Aortic Valve Show Consistent Outcomes, Lower Procedure Times Compared to Sutured Valves

PERSIST-AVR study results presented at American Association for Thoracic Surgery Annual Meeting PERSIST-AVR is the first prospective, randomized, multi-center international trial comparing Perceval ...
Stockhouse

New Data Emphasizing LivaNova Perceval Valve Durability to be Presented at the American Association for Thoracic Surgery Meeting

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that new clinical data for its sutureless surgical aortic valve, Perceval ®, will be unveiled at this year’s ...
TCTMD

LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery

LONDON, LivaNova, PLC, a global medical technology company and a leader in the treatment of cardiovascular diseases, announced the first U.S. implantation of the Perceval valve, the sutureless ...
FierceBiotech

LivaNova study shows safer outcomes from its sutureless aortic heart valve

LivaNova delivered new data from its sutureless aortic heart valve, showing fewer complications and stronger clinical outcomes compared to traditional implants built on a stent frame. An international ...
Medindia

U.S. FDA Approves LivaNova’s Perceval Sutureless Aortic Heart Valve

LivaNova, formed from the merger of Sorin and Cyberonics, has received FDA approval for its Perceval sutureless aortic heart valve to the U.S. market. The firm will begin commercial distribution of ...
Finanznachrichten

LivaNova's Perceval Sutureless Aortic Heart Valve Receives National Reimbursement in Japan to Treat Patients with Aortic Valve Disease

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced that Japan's Ministry of Health, Labour and Welfare granted national reimbursement for the Company's Perceval ...
Insurancenewsnet.com

LivaNova’s Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-on Payment from the Center for Medicare and Medicaid Services

LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced its Perceval ® sutureless aortic heart valve received ...